Clinical Trial Safety
![](https://www.wcgclinical.com/wp-content/uploads/2020/07/itemeditorimage_5f109f472e55e.png)
Clinical Trial Safety
Submitting Deviations from a Sponsor’s Adverse Event Reporting Requirements to the IRB
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2023/05/WCG-generic-visual-concepts-07.jpg)
Clinical Endpoints
New Normal or Not, Safety Reporting Matters
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2022/03/people-process-and-technology-the-right-combination-for-successful-expert-committees.png)
Clinical Endpoints
People, Process and Technology: The Right Combination for Successful Expert Committees
Podcasts![](https://www.wcgclinical.com/wp-content/uploads/2023/06/WCG-generic-visual-concept-23.jpg)
Clinical Endpoints
AIMS: Our Proprietary Web-Based Adjudication System
Videos![](https://www.wcgclinical.com/wp-content/uploads/2023/06/WCG-generic-visual-concept-23.jpg)
Clinical Trial Safety
WCG IBC Services
Solution Overviews![](https://www.wcgclinical.com/wp-content/uploads/2019/10/shutterstock_403062517.jpg)
Clinical Endpoints
Advances in Oncology Extend Lives, but Lead to New Safety Considerations for Sponsors and Investigators
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2020/07/itemeditorimage_5d3f166544f67.jpg)
Clinical Trial Safety
What are the IRB Reporting Requirements for Adverse Events?
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2023/06/WCG-generic-visual-concept-24.jpg)
Clinical Endpoints
Supporting NDA Submission for a Drug Targeting Menopausal Vasomotor Symptoms
Case Studies![](https://www.wcgclinical.com/wp-content/uploads/2020/07/itemeditorimage_5d2e121412451.jpg)
Clinical Trial Safety
Do we need to submit safety events from another site to our IRB?
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2023/06/WCG-generic-visual-concept-23.jpg)
Clinical Endpoints